Harmony Biosciences Holdings, Inc. SEC filings HRMY
Harmony Biosciences Holdings, Inc. has 460 filings in SEC EDGAR's recent list, going back to Feb 14, 2020. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2025 | — |
| 424B7 | Filing | Oct 31, 2024 | — |
| 424B7 | Filing | Oct 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| S-8 | Employee stock plan registration | May 2, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 424B5 | Prospectus supplement | Nov 9, 2021 | — |
| S-3ASR | Automatic shelf registration | Nov 9, 2021 | — |
| S-8 | Employee stock plan registration | Aug 21, 2020 | — |
| 424B4 | Prospectus | Aug 20, 2020 | — |
| S-1MEF | Filing | Aug 18, 2020 | — |
| S-1/A | Amended registration statement | Aug 13, 2020 | — |
| S-1/A | Amended registration statement | Aug 11, 2020 | — |
| S-1/A | Amended registration statement | Aug 6, 2020 | — |
| S-1 | Registration statement | Jul 27, 2020 | — |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRMY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802665
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.